wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50051034-2B90EB83-A4CB-4D5D-BC12-9A1DFBEBADF4
Q50051034-2B90EB83-A4CB-4D5D-BC12-9A1DFBEBADF4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50051034-2B90EB83-A4CB-4D5D-BC12-9A1DFBEBADF4
Improving immune-vascular crosstalk for cancer immunotherapy.
P2860
Q50051034-2B90EB83-A4CB-4D5D-BC12-9A1DFBEBADF4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50051034-2B90EB83-A4CB-4D5D-BC12-9A1DFBEBADF4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d7d24efd739d5d740e564147c9a41651d0b1415
P2860
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.